Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on enzyme-based solutions for pharmaceutical manufacturing, today announced that it plans to attend the 2026 BIO International ...

BASEL, Switzerland & SAN FRANCISCO--(BUSINESS WIRE)--Granite Bio AG, a clinical-stage immunology company, has emerged from stealth with $100 million in funding. This includes a $30 million Series A ...